Tavrin Ivan's Form 4 filing
Kismet Acquisition Three Corp. (KIII) · filed May 6, 2022
- Accession no.
- 0001213900-22-024523
- Filed
- May 6, 2022
- Trade date
- Apr 29, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 derivative transaction. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tavrin IvanCIK 0001819830 | Director, Officer (Chairman and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 29, 2022 | Class A Ordinary Shares | PPurchaseDisposed | −5,996,250 | –F2 | – | 7,687,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The Reporting Person has sole voting and investment power over the reported securities, which are held directly by Kismet Sponsor Limited (the "Sponsor"). On April 29, 2022, a 100% interest in the Sponsor was transferred to the Reporting Person in exchange for shares of another company upon the completion of a series of transactions. As a result of the transactions, the Reporting Person holds an indirect 100% interest in the Sponsor.
Referenced by the price of 1 transaction in Table II.